Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-081198)

Filing Details

Accession Number:: 0000950170-25-081198
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-03 18:30:03
Reporting Period:: 2025-06-03

Filing Date:: 2025-06-03
Accepted Time:: 2025-06-03 18:30:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1815442	Kymera Therapeutics Inc.	KYMR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1638474	W. Jeffrey Albers	C/O Kymera Therapeutics, Inc. 500 North Beacon Street, 4Th Floor Watertown MA 02472		No	No	No	No

Transaction Summary

Sold:	6,349 shares	Avg. Price: $49.00	Total Value: $311,101.00

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-06-03	6,349	$10.34	6,349	No	4	M	Direct
Common Stock	Disposition	2025-06-03	6,349	$49.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-06-03	6,349	$0.00	6,349	$10.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,000		2030-09-03	No	4	M	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 20, 2024 adopted by the reporting person.
The shares underlying this stock option are fully vested and exercisable.